These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4046454)

  • 21. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG; Stevens MJ
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.
    Ranjan M; Nayak S; Rao BS
    Mol Vis; 2006 Sep; 12():1077-85. PubMed ID: 17093392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification.
    Gupta SK; Srivastava S; Trivedi D; Joshi S; Halder N
    Curr Eye Res; 2005 Jul; 30(7):583-91. PubMed ID: 16020293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lens in diabetes.
    Bron AJ; Sparrow J; Brown NA; Harding JJ; Blakytny R
    Eye (Lond); 1993; 7 ( Pt 2)():260-75. PubMed ID: 7607346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats.
    Suryanarayana P; Saraswat M; Mrudula T; Krishna TP; Krishnaswamy K; Reddy GB
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2092-9. PubMed ID: 15914628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
    Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DeltaFosB-induced cataract.
    Kelz MB; Kuszak JR; Yang Y; Ma W; Steffen C; Al-Ghoul K; Zhang YJ; Chen J; Nestler EJ; Spector A
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3523-38. PubMed ID: 11006248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in calpain II mRNA in young rat lens during maturation and cataract formation.
    Ma H; Shih M; Throneberg DB; David LL; Shearer TR
    Exp Eye Res; 1997 Mar; 64(3):437-45. PubMed ID: 9196396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anything new concerning the human lens and senile cataract (author's transl)].
    Nordmann J
    J Fr Ophtalmol; 1981; 4(5):359-73. PubMed ID: 6273466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion.
    Mitton KP; Linklater HA; Dzialoszynski T; Sanford SE; Starkey K; Trevithick JR
    Exp Eye Res; 1999 Sep; 69(3):279-89. PubMed ID: 10471336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [X-ray-induced cataract as a model for investigating cataractogenesis (author's transl)].
    Bergeder HD; Rink H; Hockwin O
    Klin Monbl Augenheilkd; 1982 Jan; 180(1):13-6. PubMed ID: 7077987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protein-condensation diseases--molecular basis of cataract formation].
    Fankhauser F; Ricka J; Rol P; Kwasniewska S; Niederer P
    Klin Monbl Augenheilkd; 2000 Feb; 216(2):75-8. PubMed ID: 10730221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical aspects and experimental findings in so-called senile cataracts. Determination of status].
    Pau H; Hockwin O; Eckerskorn U
    Klin Monbl Augenheilkd; 1988 Jun; 192(6):677-85. PubMed ID: 3062247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.
    Abdelkader H; Alany RG; Pierscionek B
    J Pharm Pharmacol; 2015 Apr; 67(4):537-50. PubMed ID: 25643848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of cataract development in WNIN-obese rats due to accumulation of intralenticular sorbitol.
    Reddy PY; Giridharan NV; Balakrishna N; Validandi V; Pullakhandam R; Reddy GB
    IUBMB Life; 2013 May; 65(5):472-8. PubMed ID: 23504868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lens and cataract research of the 20th century: a review of results, errors and misunderstandings.
    Hockwin O; Kojima M; Müller-Breitenkamp U; Wegener A
    Dev Ophthalmol; 2002; 35():1-11. PubMed ID: 12061266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs designed to maintain the transparence of the ocular lens.
    Chanalet L; Lapalus P
    Fundam Clin Pharmacol; 1994; 8(4):322-41. PubMed ID: 7851838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of senile cataract formation.
    Chylack LT
    Ophthalmology; 1984 Jun; 91(6):596-602. PubMed ID: 6431351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.